LaVoie Group Adds Analytics Software Company to Client Roster i3 Analytics Develops Web-based Software for Pharma, Biotech Industries Business Wire CAMBRIDGE, Mass. -- November 16, 2012 LaVoie Strategic Communications, Inc. “LaVoie Group,” a firm with a proven track record of building value for health science innovations through integrated communications and investor relations, is pleased to announce that it was selected in a competitive pitch to be the PR agency for i3 Analytics, a Maryland company providing deep insight into unstructured data and pharmaceutical industry trends. “i3 Analytics is a young, innovative company that provides a web-based software to pharmaceutical companies and related industries, enabling them to make business development, R & D and other decisions based on accurate and efficient analysis of data from scientific research, clinical trials and regulatory submissions,” said Donna LaVoie, president and CEO of LaVoie Group. “We are thrilled to be partnering with the i3 team.” The leadership team at i3 Analytics selected LaVoie Group because the firm has significant experience in the life sciences and health care sectors, enhancing i3’s access to the industry. “LaVoie Group has a strong reputation and wide reach within life sciences, biotechnology, pharmaceuticals, device and health care,” said Will Zerhouni, president and CEO of i3. “LaVoie Group’s strategic counsel, proprietary database and execution add value to our business development efforts.” Since forming in 2011, i3 has worked exclusively on behalf of one of the world’s top-five pharmaceutical companies. Now the Biopharma Navigator, developed in partnership with that company, is available for small to mid-size biotech and pharmaceutical companies and other life science companies. About i3 Analytics i3 Analytics is empowering biopharmaceutical companies and related industries to make fast, informed and intelligent decisions on business strategy, clinical affairs and product development. i3 Analytics’ flagship product is the Biopharma Navigator, analytics software that provides an intuitive map of the biopharma landscape. The Biopharma Navigator is a single entry point that provides access to focused search lenses, including the ClinicalTrials Navigator, BioExpert Navigator, and BioNews Navigator. The company’s intuitive, accessible analytics tools navigate the complex world of data from scientific research, clinical trials and regulatory submissions in the US and Europe. For more information, visit: http://www.i3analytics.com/ About LaVoie Group LaVoie Group partners with its clients achieve their business goals by providing strategic consulting and integrated communications programs that properly position, engage target customers and stakeholders to create brand value. LaVoie Group is part of the IPREX network of global agencies. LaVoie Group clients are industry leaders in healthcare and government markets, including, Aegerion Pharmaceuticals, AliveCor, Vertex Pharmaceuticals, BIO, Radius Health, Novadaq Technologies, Rockwell Medical, the Commonwealth of Massachusetts, Flagship Ventures, MPM Capital, Hydra Biosciences and Xcovery Group of companies. LaVoie Group is part of INC. 500/500 private company list and is ranked by O’Dwyer’s PR Report as one of the leading independent healthcare PR firms in the U.S. and has been honored for the past four years by the League of American Communications Professionals (LACP) for best agency awards, including the 2011 “Best Small Agency”. The agency has been honored by eighteen awards in the last three years. Contact: LaVoie Group David Connolly, 617-374-8800 Vice President firstname.lastname@example.org
LaVoie Group Adds Analytics Software Company to Client Roster
Press spacebar to pause and continue. Press esc to stop.